HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ingo Bauerfeind Selected Research

Docetaxel (Taxotere)

4/2010Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
4/2010Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ingo Bauerfeind Research Topics

Disease

41Breast Neoplasms (Breast Cancer)
10/2021 - 01/2003
17Neoplasms (Cancer)
12/2020 - 01/2003
5Neoplasm Metastasis (Metastasis)
10/2021 - 10/2008
2Triple Negative Breast Neoplasms
01/2021 - 12/2020
2Cognitive Dysfunction
10/2017 - 12/2010
2Pathologic Complete Response
04/2010 - 06/2009
2Ovarian Neoplasms (Ovarian Cancer)
04/2009 - 09/2006
1Peripheral Nervous System Diseases (PNS Diseases)
04/2019
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017
1Chemotherapy-Related Cognitive Impairment
12/2010
1Febrile Neutropenia
04/2010
1Conjunctivitis
04/2010
1Cardiotoxicity
04/2010
1Diarrhea
04/2010
1Hand-Foot Syndrome
04/2010
1Edema (Dropsy)
04/2010
1Neutropenia
06/2009
1Infections
06/2009
1Anemia
06/2009
1Thrombocytopenia (Thrombopenia)
06/2009
1Malnutrition (Nutritional Deficiencies)
04/2009
1Weight Loss (Weight Reduction)
04/2009
1Noninfiltrating Intraductal Carcinoma (DCIS)
05/2003

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
12/2020 - 01/2003
4Epirubicin (Ellence)FDA LinkGeneric
04/2010 - 05/2007
3taxaneIBA
01/2021 - 04/2010
3AnthracyclinesIBA
01/2021 - 04/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2010 - 05/2007
2human ERBB2 proteinIBA
12/2020 - 04/2010
2Carcinoembryonic AntigenIBA
08/2011 - 03/2008
2Trastuzumab (Herceptin)FDA Link
04/2010 - 04/2010
2Capecitabine (Xeloda)FDA Link
04/2010 - 04/2010
2Docetaxel (Taxotere)FDA Link
04/2010 - 04/2010
2Paclitaxel (Taxol)FDA LinkGeneric
06/2009 - 05/2007
2Cytostatic AgentsIBA
01/2008 - 03/2006
2SteroidsIBA
05/2003 - 01/2003
1Pharmaceutical PreparationsIBA
09/2016
1Taxoids (Taxanes)IBA
01/2016
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1OF 743IBA
08/2015
1Ibandronic Acid (Boniva)FDA Link
10/2013
1Diphosphonates (Bisphosphonates)IBA
10/2013
1Mucin-1 (CA 15-3 Antigen)IBA
08/2011
1ErbB Receptors (EGF Receptor)IBA
04/2010
1Growth Factor ReceptorsIBA
01/2010
1Letrozole (Femara)FDA LinkGeneric
01/2010
1Estrogen ReceptorsIBA
01/2010
1Lapatinib (GW572016)FDA Link
01/2010
1Aromatase InhibitorsIBA
08/2009
1Estrogens (Estrogen)FDA Link
11/2008
1Annexin A5IBA
10/2008
1ThrombinFDA Link
10/2008
1Prothrombin (Factor II)IBA
10/2008
1AntigensIBA
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2008
1von Willebrand FactorIBA
03/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2004
1Progesterone Receptors (Progesterone Receptor)IBA
05/2003
1Cyclin D1IBA
05/2003
1ParaffinIBA
05/2003
1EnzymesIBA
01/2003
1ImmunosorbentsIBA
01/2003
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2003

Therapy/Procedure

21Therapeutics
12/2020 - 01/2003
14Drug Therapy (Chemotherapy)
04/2019 - 03/2004
12Neoadjuvant Therapy
10/2021 - 05/2007
1Operative Surgical Procedures
10/2021
1Radiotherapy
10/2021
1Mastectomy (Mammectomy)
01/2017
1Life Support Care
06/2013
1Prophylactic Mastectomy
09/2006
1Lymph Node Excision (Lymph Node Dissection)
04/2004
1Radical Mastectomy
03/2004